North America holds a notable position in the Amniocentesis Needle Market, driven by increasing demand for advanced prenatal diagnostic procedures, rising awareness about genetic screening, and the availability of sophisticated maternal healthcare services. The United States and Canada are witnessing growing adoption of amniocentesis procedures for detecting chromosomal abnormalities, genetic...